Patent ID: 7449454

Claim:
A method for treating a disease or condition comprising providing a patient having neoplastic tissue comprising sarcoma, lymphoma, leukemia, carcinoma, brain metastases, glioblastoma, and prostate cancer with an effective amount of a compound of Formula 1: wherein M represents a metal cation selected from Gd +3 or Lu +3 ; AL is an apical ligand with the proviso that AL is not derived from acetic acid, nitric acid, or hydrochloric acid; n is 2; R 1 , R 1a , R 2 , R 3 , R 4 , R 4a , R 7 , R 8 , R 10 , R 11 , R 12 , and R 13 are independently selected from hydrogen, acyl, acyloxy, optionally substituted alkenyl, optionally substituted alkoxy, optionally substituted alkyl, optionally substituted alkynyl, optionally substituted amino, optionally substituted aryl, optionally substituted aryloxy, carboxyl, (optionally substituted alkoxy)carbonyl, (optionally substituted amino)carbonyl, (optionally substituted amino)carbonyloxy, optionally substituted cycloalkyl, optionally substituted cycloalkenyl, optionally substituted heteroaryl, optionally substituted heteroaryloxy, optionally substituted heterocyclyl, optionally substituted heterocyclooxy, and hydroxyl; and R 6 and R 9 are hydrogen; and providing the patient with either a chemotherapeutic compound, or providing the area in proximity to the neoplastic tissue with a therapeutic energy means selected from photoirradiation and ionizing radiation.